|
2025
|
G/S
|
Pharmaceuticals; Medical preparations; Sanitary preparations for medical purposes. |
|
|
G/S
|
Pharmaceuticals; Medical preparations; Sanitary preparations for medical use. |
|
2024
|
G/S
|
Analgesics. |
|
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations for the treatment of osteoarthritis, rheumat... |
|
|
G/S
|
Pre-filled syringes for medical purposes. |
|
|
Invention
|
Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives. The inve... |
|
|
G/S
|
Video and audio recordings; films; compact discs; DVDs; CD ROMs; computer software; computer soft... |
|
2023
|
Invention
|
Sulfoximines as inhibitors of nav1.8. VV1.8 and can be used in the treatment of pain. |
|
|
G/S
|
Pharmaceutical and veterinary preparations; hygienic preparation for medical purposes; sanitary p... |
|
2022
|
Invention
|
Substituted pyrazole amides. The present invention relates to compounds according to general form... |
|
|
G/S
|
Sanitary preparations for medical purposes; Pharmaceuticals, namely, pharmaceutical preparations ... |
|
|
G/S
|
Pharmaceuticals; medical preparations; sanitary preparations
for medical purposes. |
|
|
G/S
|
Downloadable software for computers and mobile devices for measuring, monitoring, recording, disp... |
|
|
Invention
|
Topical capsaicinoids for treating a neuropathic condition in covid-19 patients. The invention re... |
|
|
Invention
|
Tapentadol for treating neuropathic pain in covid-19 patients. The invention relates to a pharmac... |
|
|
G/S
|
Pharmaceuticals namely pharmaceutical preparations for the treatment of osteoarthritis, rheumatoi... |
|
|
G/S
|
Sanitary preparations for medical purposes; Pharmaceuticals; Medical preparations. |
|
|
G/S
|
Sanitary preparations for medical purposes; pharmaceuticals; medical preparations |
|
|
G/S
|
Sanitary preparations for medical purposes; pharmaceuticals;
medical preparations. |
|
2021
|
Invention
|
Sustained release dosage forms of a salt of tapentadol with l-(+)-tartaric acid. The invention re... |
|
|
G/S
|
Pharmaceutical preparations and substances. |
|
|
Invention
|
Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor. The invention... |
|
|
Invention
|
Multiparticulate dosage form containing eva copolymer and additional excipient. The invention rel... |
|
|
Invention
|
Dosage form comprising hot-melt extruded pellets containing eva copolymer and gliding agent. The ... |
|
|
Invention
|
Regimen for repeated topical application of capsaicin patch. The invention relates to a regimen f... |
|
|
Invention
|
Repeated topical application of capsaicin patch for treating initial non-responders. The inventio... |
|
|
Invention
|
Scored tablet. The invention relates to a scored tablet comprising Tapentadol or a physiologicall... |
|
|
Invention
|
Dosage form providing prolonged release of tapentadol phosphoric acid salt. The invention relates... |
|
|
Invention
|
Quinoxaline derivatives as modulators of the glucocorticoid receptor. The present invention relat... |
|
|
Invention
|
Quinoxaline derivatives. The present invention relates to compounds according to general formula ... |
|
2020
|
G/S
|
Pharmaceutical preparations for human use. |
|
|
G/S
|
Information for educational purposes in the field of medicine stored on electronic data carriers;... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Substituted pyrrolidine amides v. The invention relates to compounds according to general formula... |
|
|
Invention
|
Substituted pyrrolidine amides iv. The invention relates to compounds according to general formul... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of migraines. |
|
|
Invention
|
Substituted pyrrolidine amides iii. The invention relates to compounds according to general formu... |
|
2019
|
Invention
|
Composition for treating urinary frequency and/or urinary urgency. EE)-4-(3-fluorophenyl)-2',3',4... |
|
|
Invention
|
Method for carrying out structured rehabilitation. A method for carrying out structured rehabilit... |
|
|
Invention
|
Substituted triazolo quinoxaline derivatives. The present invention relates to compounds accordin... |
|
|
Invention
|
Further substituted triazolo quinoxaline derivatives. The present invention relates to compounds ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of pain and inflammation |
|
|
G/S
|
Video and audio recordings; films; compact discs; DVDs; CD ROMs; computer software and publicatio... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of pain and inflammation. |
|
|
Invention
|
Methods of treating complex regional pain syndrome (crps) or symptoms comprising administration o... |
|
|
Invention
|
Piperidines or piperidones substituted with urea and phenyl. The present invention relates to a c... |
|
|
Invention
|
Tamper resistant formulation of ephedrine and its derivatives comprising a conversion inhibitor. ... |
|
2018
|
Invention
|
Substituted pyrrolidine amides i. The invention relates to compounds according to general formula... |
|
|
Invention
|
Substituted pyrrolidine amides ii. The invention relates to compounds according to general formul... |
|
|
Invention
|
Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride.... |
|
|
Invention
|
Treatment of vulvodynia. The invention relates to a pharmaceutical composition comprising cis-(E)... |
|
|
Invention
|
Modified release abuse deterrent dosage forms. The invention relates to a pharmaceutical dosage f... |
|
|
Invention
|
Synergistic pharmaceutical combination comprising tramadol hydrochloride and pregabalin, and use ... |
|
|
Invention
|
1,3-diaza-spiro-[3.4]-octane derivatives. The invention relates to 1,3-diaza-spiro-[3.4]-octane d... |
|
|
Invention
|
Novel substituted 3-indole and 3-indazole compounds as phosphodiesterase inhibitors. The inventio... |
|
|
Invention
|
Novel substituted indole and indazole compounds as phosphodiesterase inhibitors. The invention re... |
|
|
Invention
|
Multiparticulate oral dosage form providing prolonged release of tapentadol. The invention relate... |
|
|
Invention
|
System and method for creating a medication plan. The invention relates to a system for creating ... |
|
|
Invention
|
Composition for intravesical administration for treating bladder pain. The invention relates to a... |
|
|
Invention
|
Tapentadol as local anesthetic. The invention relates to a pharmaceutical composition comprising ... |
|
|
Invention
|
Pharmaceutical patch comprising lidocaine and diclofenac for treating neuropathic pain. The inven... |
|
|
Invention
|
Administration regimen for a pharmaceutical patch comprising lidocaine and diclofenac. The invent... |
|
2017
|
Invention
|
Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-relea... |
|
|
Invention
|
Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramado... |
|
|
Invention
|
Multiparticulate dosage form with controlled release of metamizol. The invention relates to a pha... |
|
|
Invention
|
Stable formulation for parenteral administration of tapentadol. The invention relates to an aqueo... |
|
|
Invention
|
6-membered cyclic amines or lactames substituted with urea and phenyl. The present invention rela... |
|
|
Invention
|
Tamper resistant formulation of ephedrine and its derivatives. The invention relates to a pharmac... |
|
|
Invention
|
Tamper resistant dosage form comprising an anionic polysaccharide. The invention relates to a pha... |
|
|
Invention
|
Reinforced pharmaceutical dosage form. The invention relates to a reinforced pharmaceutical dosag... |
|
|
Invention
|
Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthriti... |
